308 related articles for article (PubMed ID: 18691429)
1. Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.
Ashley EA; Pinoges L; Turyakira E; Dorsey G; Checchi F; Bukirwa H; van den Broek I; Zongo I; Urruta PP; van Herp M; Balkan S; Taylor WR; Olliaro P; Guthmann JP
Malar J; 2008 Aug; 7():154. PubMed ID: 18691429
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial.
Djallé D; Njuimo SP; Manirakiza A; Laganier R; Le Faou A; Rogier C
Malar J; 2014 Jan; 13():9. PubMed ID: 24393479
[TBL] [Abstract][Full Text] [Related]
3. High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
Adeel AA; Elnour FA; Elmardi KA; Abd-Elmajid MB; Elhelo MM; Ali MS; Adam MA; Atta H; Zamani G; Warsame M; Barrette A; Mohammady HE; Nada RA
Malar J; 2016 May; 15(1):285. PubMed ID: 27209063
[TBL] [Abstract][Full Text] [Related]
4. Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
[TBL] [Abstract][Full Text] [Related]
5. Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.
Meremikwu M; Alaribe A; Ejemot R; Oyo-Ita A; Ekenjoku J; Nwachukwu C; Ordu D; Ezedinachi E
Malar J; 2006 May; 5():43. PubMed ID: 16704735
[TBL] [Abstract][Full Text] [Related]
6. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
[TBL] [Abstract][Full Text] [Related]
7. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
8. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
Zongo I; Dorsey G; Rouamba N; Tinto H; Dokomajilar C; Guiguemde RT; Rosenthal PJ; Ouedraogo JB
Lancet; 2007 Feb; 369(9560):491-8. PubMed ID: 17292769
[TBL] [Abstract][Full Text] [Related]
9. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
Warsame M; Hassan AH; Hassan AM; Arale AM; Jibril AM; Mohamud SA; Barrette A; Muse AY; Yusuf FE; Nada RA; Amran JG
Trop Med Int Health; 2017 Apr; 22(4):415-422. PubMed ID: 28151566
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance.
Okafor HU; Shu EN; Oguonu T
J Trop Pediatr; 2010 Dec; 56(6):398-406. PubMed ID: 20144932
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.
Whegang SY; Tahar R; Foumane VN; Soula G; Gwét H; Thalabard JC; Basco LK
Malar J; 2010 Feb; 9():56. PubMed ID: 20170477
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali.
Niaré K; Dara A; Sagara I; Sissoko MS; Guindo CO; Cissé NH; Coulibaly CO; Ringwald P; Benoit-Vical F; Berry A; Djimdé AA; Doumbo OK
Am J Trop Med Hyg; 2016 Mar; 94(3):634-9. PubMed ID: 26811430
[TBL] [Abstract][Full Text] [Related]
14. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
[TBL] [Abstract][Full Text] [Related]
15. A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.
Mukhtar EA; Gadalla NB; El-Zaki SE; Mukhtar I; Mansour FA; Babiker A; El-Sayed BB
Malar J; 2007 Jul; 6():92. PubMed ID: 17631681
[TBL] [Abstract][Full Text] [Related]
16. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of antimalarial combinations for treatment of uncomplicated malaria in children in Bangui, Central African Republic].
Nambei WS; Lango Yaya E; Pounguinza S; Achonduh O; Bogon A; Lengande R; Evehe MS; Ekollo Mbange AH; Mbacham W
Med Sante Trop; 2013; 23(3):313-9. PubMed ID: 24122669
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
Saha P; Guha SK; Das S; Mullick S; Ganguly S; Biswas A; Bera DK; Chattopadhyay G; Das M; Kundu PK; Ray K; Maji AK
Antimicrob Agents Chemother; 2012 May; 56(5):2511-7. PubMed ID: 22314538
[TBL] [Abstract][Full Text] [Related]
19. Azithromycin for treating uncomplicated malaria.
van Eijk AM; Terlouw DJ
Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD006688. PubMed ID: 21328286
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
Dorsey G; Staedke S; Clark TD; Njama-Meya D; Nzarubara B; Maiteki-Sebuguzi C; Dokomajilar C; Kamya MR; Rosenthal PJ
JAMA; 2007 May; 297(20):2210-9. PubMed ID: 17519410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
